Table 1.
Patient clinical demographics.
| RA | SLE | |
|---|---|---|
| N | 6 | 6 |
| Age (years)a, b | 61.72 (22.1–77.23) | 38.3 (23.1–62.7) |
| Disease duration (years)a | 1.8 (0–5.2) | 4.2 (0–9.7) |
| Gender F/M | 3/3 | 5/1 |
| ACPA pos/neg | 5/1 | 0 |
| Anti-dsDNA pos/neg | 0 | 6/0 |
| Disease activity scorea | 4.04 (3.26–5.21)c | 6 (0–12)a,d |
| CURRENT DRUG TREATMENTS | ||
| – Methotrexate | 4 | 1 |
| – Sulphasalazine | 1 | 0 |
| – Hydroxychloriquine | 2 | 4 |
| – Prednisolone | 0 | 4 |
| – Belimumab | 0 | 2 |
| – Mycophenolate mofetil | 0 | 2 |
a
Mean (range).
b
T-test (p = 0.05).
c
DAS28.
d
SLEDAI scores available for 2/6 patients.